In Vitro and In Vivo Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.

Gupta, Aanchal; Malik, Saquib; Kaminski, Monica; Landman, David; Quale, John M

In Vitro and In Vivo Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.

Gupta, Aanchal; Malik, Saquib; Kaminski, Monica; Landman, David; Quale, John M.

Affiliation

Gupta A; Infectious Diseases Division, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Malik S; Infectious Diseases Division, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Kaminski M; Infectious Diseases Division, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Landman D; Infectious Diseases Division, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Quale JM; Infectious Diseases Division, SUNY Downstate Medical Center, Brooklyn, New York, USA.

Microb Drug Resist ; 28(4): 419-424, 2022 Apr.

Article in En | MEDLINE | ID: mdl-35451880

Subject(s)
Key words

ESBL; Enterobacteriaceae; extended spectrum

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli / Klebsiella pneumoniae Type of study: Prognostic_studies Language: En Journal: Microb Drug Resist Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google